This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/health-27709132

The article has changed 4 times. There is an RSS feed of changes available.

Version 0 Version 1
Hospital feed company 'saddened' by baby death Hospital feed company 'saddened' by baby death
(about 4 hours later)
The manufacturer of a hospital feed "strongly linked" to the death of one baby and illness of 14 others has said it is "saddened" by what has happened.The manufacturer of a hospital feed "strongly linked" to the death of one baby and illness of 14 others has said it is "saddened" by what has happened.
ITH Pharma managing director Karen Hamling said it was co-operating fully with an inquiry by health officials.ITH Pharma managing director Karen Hamling said it was co-operating fully with an inquiry by health officials.
The baby died from blood poisoning at St Thomas' Hospital in south London from suspected contaminated drip food.The baby died from blood poisoning at St Thomas' Hospital in south London from suspected contaminated drip food.
Public Health England said babies at six hospitals developed septicaemia from the Bacillus cereus bacterium.Public Health England said babies at six hospitals developed septicaemia from the Bacillus cereus bacterium.
'Establish facts''Establish facts'
Ms Hamling said in a statement: "ITH Pharma is very saddened to hear about the death of a baby in hospital, and that 14 others are ill with septicaemia.Ms Hamling said in a statement: "ITH Pharma is very saddened to hear about the death of a baby in hospital, and that 14 others are ill with septicaemia.
"ITH Pharma is a specialist manufacturer of parenteral nutrition, which is given to babies in neonatal intensive care units."ITH Pharma is a specialist manufacturer of parenteral nutrition, which is given to babies in neonatal intensive care units.
"The products in question, which are no longer in circulation, are made to order for individual patients on a daily basis, in response to bespoke orders from hospitals."The products in question, which are no longer in circulation, are made to order for individual patients on a daily basis, in response to bespoke orders from hospitals.
"We are co-operating fully with the MHRA (Medicines and Healthcare products Regulatory Agency) in the investigation, and are doing everything we can to help them establish the facts in this case as quickly as possible.""We are co-operating fully with the MHRA (Medicines and Healthcare products Regulatory Agency) in the investigation, and are doing everything we can to help them establish the facts in this case as quickly as possible."
Public Health England (PHE) said the cases were "strongly linked" with a number of batches of a particular form of the intravenous liquid made by the London-based company.Public Health England (PHE) said the cases were "strongly linked" with a number of batches of a particular form of the intravenous liquid made by the London-based company.
Responding well Paul Cosford, PHE's director of health protection, told BBC Radio 4's Today programme that a possible point when contamination entered the products last week had been identified.
Fed into bloodstream
The baby died on Sunday after being diagnosed the previous day.The baby died on Sunday after being diagnosed the previous day.
The babies affected, many of whom were premature, were being cared for in neonatal intensive care units and were given the feed direct to their bloodstream as they could not be fed by mouth.The babies affected, many of whom were premature, were being cared for in neonatal intensive care units and were given the feed direct to their bloodstream as they could not be fed by mouth.
The cases were reported at:The cases were reported at:
The hospitals said the surviving babies were responding well to antibiotics and their parents had been informed.The hospitals said the surviving babies were responding well to antibiotics and their parents had been informed.
An investigation has been launched by PHE and the MHRA.An investigation has been launched by PHE and the MHRA.
PHE said inquiries with ITH Pharma had identified "an incident that might have caused the contamination".PHE said inquiries with ITH Pharma had identified "an incident that might have caused the contamination".
A PHE spokeswoman said: "Many of the babies were premature and very vulnerable and one baby has sadly died but the others are responding to antibiotic treatment."A PHE spokeswoman said: "Many of the babies were premature and very vulnerable and one baby has sadly died but the others are responding to antibiotic treatment."
ITH Pharma has launched a product recall to which the MHRA has issued an alert to hospitals.ITH Pharma has launched a product recall to which the MHRA has issued an alert to hospitals.
Bacillus cereusBacillus cereus
PHE said doctors had been given advice on identifying any potential cases of infection and how to dispose of affected stock.PHE said doctors had been given advice on identifying any potential cases of infection and how to dispose of affected stock.
PHE incident director Prof Mike Catchpole "This is a very unfortunate incident and PHE have been working closely with the MHRA to investigate how these babies could have become infected. PHE incident director Professor Mike Catchpole said: "Given that the bacteria is widely spread in the environment, we are continuing to investigate any other potential sources of infection. However, all our investigations to date indicate that the likely source of the infection has been identified.
"Given that the bacteria is widely spread in the environment, we are continuing to investigate any other potential sources of infection. However, all our investigations to date indicate that the likely source of the infection has been identified.
"We have acted quickly to investigate this issue alongside the MHRA and we have taken action to ensure that the affected batches and any remaining stock of this medicine is not being used in hospitals.""We have acted quickly to investigate this issue alongside the MHRA and we have taken action to ensure that the affected batches and any remaining stock of this medicine is not being used in hospitals."
'Rigorous inspection''Rigorous inspection'
Adam Burgess, manager of the MHRA's defective medicines reporting centre, said: "Patient safety is our top priority and we are working alongside PHE to establish what has happened. Adam Burgess, manager of the MHRA's defective medicines reporting centre, said: "We have sent inspectors to the manufacturer's facility to carry out a detailed and rigorous inspection and we have ensured that the potentially affected medicine is recalled."
"We have sent inspectors to the manufacturer's facility to carry out a detailed and rigorous inspection and we have ensured that the potentially affected medicine is recalled."
Officials said they were not expecting any more cases.Officials said they were not expecting any more cases.
Dr Martin Ward Platt, of the Royal College of Paediatrics and Child Health, said blood poisoning caused by Bacillus cereus was extremely rare.Dr Martin Ward Platt, of the Royal College of Paediatrics and Child Health, said blood poisoning caused by Bacillus cereus was extremely rare.
"Any baby developing such a serious infection can suffer from fever, pauses in their breathing and vomiting, amongst other symptoms," he said. "It is very important to treat suspected infections as early as possible as they can be fatal.""Any baby developing such a serious infection can suffer from fever, pauses in their breathing and vomiting, amongst other symptoms," he said. "It is very important to treat suspected infections as early as possible as they can be fatal."
"It seems that the recently reported infections, and a tragic death, have been associated with an intravenous feeding product."It seems that the recently reported infections, and a tragic death, have been associated with an intravenous feeding product.
"The immediate response has been for the affected hospitals to stop using the product, and it is generally easy for them to switch to alternative suppliers so that babies who need intravenous feeding do not go without it for a prolonged period."The immediate response has been for the affected hospitals to stop using the product, and it is generally easy for them to switch to alternative suppliers so that babies who need intravenous feeding do not go without it for a prolonged period.
"Naturally, parents whose babies are in intensive care anywhere in the country may be concerned and if so I would urge them to talk to the doctors and nurses looking after their baby.""Naturally, parents whose babies are in intensive care anywhere in the country may be concerned and if so I would urge them to talk to the doctors and nurses looking after their baby."